Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:HUM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHUMHumana$290.10+0.6%$244.92$206.87▼$382.72$34.89B0.441.73 million shs939,195 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHUMHumana+0.10%+4.67%+30.88%+17.07%-18.46%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHUMHumana4.2646 of 5 stars2.23.02.53.93.41.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHUMHumana 2.30Hold$281.43-2.99% DownsideCurrent Analyst Ratings BreakdownLatest PGL, VANQ, HUM, and HAT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/14/2025HUMHumanaWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$348.00 ➝ $344.007/31/2025HUMHumanaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$268.00 ➝ $275.007/31/2025HUMHumanaMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$290.00 ➝ $277.007/31/2025HUMHumanaPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$288.00 ➝ $272.007/25/2025HUMHumanaRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$300.00 ➝ $297.007/18/2025HUMHumanaWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$348.007/16/2025HUMHumanaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$280.00 ➝ $260.006/17/2025HUMHumanaBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$320.00 ➝ $260.006/17/2025HUMHumanaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetHold ➝ Hold$305.00 ➝ $280.006/12/2025HUMHumanaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$273.00 ➝ $268.00(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHUMHumana$117.76B0.30$24.12 per share12.03$152.11 per share1.91Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHUMHumana$1.21B$13.0322.2622.091.691.28%13.67%4.85%10/29/2025 (Estimated)Latest PGL, VANQ, HUM, and HAT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025HUMHumana$6.32$6.27-$0.05$4.51$31.85 billion$32.39 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHUMHumana$3.541.22%N/A27.17%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHUMHumana0.691.951.95Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHUMHumana92.38%Insider OwnershipCompanyInsider OwnershipHUMHumana0.37%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHUMHumana65,680120.27 million119.83 millionOptionablePGL, VANQ, HUM, and HAT HeadlinesRecent News About These CompaniesCNC vs. HUM: Which Managed-Care Stock is a Smarter Investment?2 hours ago | zacks.comHumana Medicare Advantage Review (2025) – Forbes AdvisorAugust 20 at 4:06 AM | forbes.comAnnual Humana Community Day Expands Nationwide to Deepen Employee Impact in Local CommunitiesAugust 19 at 9:31 AM | gurufocus.comVersor Investments LP Purchases 5,401 Shares of Humana Inc. (NYSE:HUM)August 19 at 7:53 AM | marketbeat.comHumana Inc. (NYSE:HUM) Shares Sold by State of New Jersey Common Pension Fund DAugust 19 at 5:57 AM | marketbeat.comAberdeen Group plc Has $34.69 Million Stock Holdings in Humana Inc. (NYSE:HUM)August 19 at 5:38 AM | marketbeat.comDimensional Fund Advisors LP Increases Stock Position in Humana Inc. (NYSE:HUM)August 19 at 5:38 AM | marketbeat.comHumana Inc. $HUM Shares Purchased by Public Sector Pension Investment BoardAugust 19 at 4:45 AM | marketbeat.comHumana Inc. (NYSE:HUM) Receives Consensus Rating of "Hold" from BrokeragesAugust 19 at 4:08 AM | marketbeat.comZacks Research Comments on Humana's Q3 Earnings (NYSE:HUM)August 19 at 2:11 AM | marketbeat.comRep. Lisa C. McClain Buys Humana Inc. (NYSE:HUM) SharesAugust 18 at 11:04 PM | marketbeat.comHumana must face class action suit over use of AI in denying post-acute careAugust 18 at 10:17 PM | mcknights.comMHere's Why Humana (HUM) is a Strong Momentum StockAugust 18 at 10:50 AM | zacks.comCanada's Wilkerson, Humana-Paredes golden again at Montreal beach volleyball eventAugust 18 at 4:56 AM | cbc.caHumana-Paredes says it's 'a dream come true' to win again in front of Canadian crowdAugust 18 at 4:56 AM | msn.comHumana Inc. (NYSE:HUM) Shares Sold by Prudential PLCAugust 18 at 4:49 AM | marketbeat.comZacks Research Weighs in on Humana's Q3 Earnings (NYSE:HUM)August 18 at 2:13 AM | americanbankingnews.comFY2025 Earnings Estimate for Humana Issued By Zacks ResearchAugust 17 at 10:27 AM | marketbeat.comBrandywine Global Investment Management LLC Has $51 Million Position in Humana Inc. (NYSE:HUM)August 17 at 6:54 AM | marketbeat.comSector Gamma AS Has $6.62 Million Stock Holdings in Humana Inc. (NYSE:HUM)August 17 at 6:54 AM | marketbeat.comFox Run Management L.L.C. Buys New Position in Humana Inc. (NYSE:HUM)August 17 at 6:10 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025Why the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 2025AbbVie Stock Eyes Breakout as Pipeline and Profits GrowBy Chris Markoch | July 31, 2025PGL, VANQ, HUM, and HAT Company DescriptionsHumana NYSE:HUM$290.10 +1.85 (+0.64%) Closing price 03:59 PM EasternExtended Trading$286.00 -4.10 (-1.41%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Target: Missing the Mark in 2025—Downtrend May Continue Renaissance Hedge Fund Adds NVIDIA, Follows Buffett Into UNH Archer's Flight Milestones & Defense Wins Excite Wall Street Home Depot Holds Gains After Narrow Q2 Misses 2 Powerful Forces Now Back Intel's Turnaround The Case for Buying NVIDIA Stock Ahead of the Robotics Surge Medtronic: The Opportunity Gets Healthier for Income Investors Tesla's Breakout: Why This Rally Looks Far From Over Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.